Not applicableNot Yet RecruitingNCT07585526
What this trial is testing
Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.
Who this might be right for
MASLDChronic Kidney Diseases
Institute of Liver and Biliary Sciences, India 160